Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › VA › Norfolk › NPI 1912919481
Behavioral

Childrens Hospital of the Kings Daughters INC

Childrens Hospital of the Kings Daughters INC was paid $288.16M by Medicaid between Jan 2018 and Dec 2024, across 586 billing codes. Its largest line is 92507, Treatment of speech, language, voice, communication, and/or auditory processing disorder — 8.2% of everything it billed.

33Billing provider infoCHILDRENS HOSPITAL OF THE KINGS DAUGHTERS INC
NORFOLK, VA 23507
33aNPI1912919481assigned 08/13/2006
33bProvider typeClinical Social Worker
28Total paid$288.16M
24GClaims3,749,193
24DCodes billed586
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Clinical Social Worker providers in Virginia

Rank by total paid#1 of 309
Median peer was paid$37K
This provider vs. median7,741×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official ABSHIRE, KATHRYN controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$2.0M$4.0M$6.0M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018452,571$27.97M
2019462,321$25.81M
2020377,461$29.63M
2021567,444$41.43M
2022628,011$51.47M
2023676,411$57.64M
2024incomplete584,974$54.22M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder 8.2% 186,498 59,845 $23.75M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 7.7% 115,764 106,716 $22.25M
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 6.7% 138,790 129,975 $19.25M
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 4.3% 136,700 126,608 $12.43M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 3.7% 35,496 32,959 $10.78M
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 3.6% 52,600 49,935 $10.52M
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 3.3% 128,004 36,927 $9.60M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 3.2% 25,947 24,040 $9.29M
97530 Therapeutic activities, direct patient contact, each 15 minutes 2.6% 109,758 36,882 $7.42M
99282 Emergency department visit for the evaluation and management, low to moderate severity 2.4% 39,787 36,904 $7.04M
41899 Unlisted procedure, dentoalveolar structures 2.4% 4,087 3,852 $7.01M
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 2.2% 29,828 27,762 $6.42M
574 more codes
J1745 Injection, infliximab, excludes biosimilar, 10 mg 1.7% 2,225 $4.77M
95810 Polysomnography; sleep staging with 4 or more additional parameters 1.5% 4,619 $4.38M
42820 Tonsillectomy and adenoidectomy; younger than age 12 1.5% 2,191 $4.33M
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 1.5% 6,609 $4.27M
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple 1.4% 4,792 $4.10M
69436 Tympanostomy (requiring insertion of ventilating tube), general anesthesia 1.4% 3,039 $3.96M
93304 1.4% 8,604 $3.93M
96361 Intravenous infusion, hydration; each additional hour 1.3% 10,449 $3.81M
67311 1.3% 1,399 $3.78M
G0378 Hospital observation service, per hour 1.2% 12,412 $3.58M
95782 <1% 2,690 $2.86M
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 37,565 $2.64M
70551 Magnetic resonance imaging, brain; without contrast material <1% 4,547 $2.53M
42830 <1% 1,354 $2.52M
99203 Doctor's office visit, new patient (routine) <1% 23,739 $2.44M
J1569 Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg <1% 1,362 $2.26M
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 36,277 $2.02M
76770 <1% 10,066 $1.96M
96110 Developmental screening, with scoring and documentation, per standardized instrument <1% 2,478 $1.75M
92523 <1% 10,854 $1.71M
70450 Computed tomography, head or brain; without contrast material <1% 4,500 $1.69M
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 2,192 $1.57M
99215 Doctor's office visit, returning patient (complex) <1% 11,610 $1.56M
87631 <1% 43,812 $1.55M
93303 Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study <1% 3,050 $1.54M
93325 <1% 14,774 $1.51M
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 5,854 $1.46M
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 9,061 $1.40M
54161 <1% 728 $1.32M
94010 <1% 19,291 $1.30M
71046 Radiologic examination, chest; 2 views <1% 34,915 $1.22M
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) <1% 10,064 $1.20M
74177 Computed tomography, abdomen and pelvis; with contrast material <1% 1,987 $1.20M
97161 <1% 6,545 $1.16M
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 5,729 $1.16M
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 7,086 $1.15M
P9016 Red blood cells, leukocytes reduced, each unit <1% 2,097 $1.13M
45380 Colonoscopy, flexible; with biopsy, single or multiple <1% 1,547 $1.12M
99217 <1% 1,902 $1.10M
93308 <1% 2,914 $1.09M
95819 <1% 2,747 $1.07M
99218 <1% 2,482 $1.02M
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward <1% 9,992 $979K
36430 <1% 2,517 $918K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) <1% 7,177 $906K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 1,919 $829K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 23,916 $816K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 25,199 $787K
97162 <1% 4,409 $772K
87486 <1% 44,027 $765K
J3490 Unclassified drugs <1% 105,041 $731K
80053 Comprehensive metabolic panel <1% 51,129 $715K
J3535 Drug administered through a metered dose inhaler <1% 25,022 $703K
74018 <1% 14,565 $701K
97165 <1% 4,176 $696K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 2,791 $679K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) <1% 5,645 $660K
90791 Psychiatric diagnostic evaluation <1% 3,708 $627K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 2,680 $603K
12011 <1% 2,329 $597K
0202U Oncology (prostate), multianalyte, gene expression profiling <1% 2,448 $555K
93321 <1% 11,468 $555K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 25,130 $552K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 47,086 $533K
93976 <1% 4,317 $511K
95812 <1% 972 $504K
87581 <1% 44,023 $491K
74019 <1% 12,088 $484K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 9,755 $474K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 82,423 $455K
72082 <1% 5,396 $451K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 7,113 $448K
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) <1% 1,778 $446K
96161 <1% 12,980 $433K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) <1% 3,265 $431K
70360 <1% 6,460 $421K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 883 $407K
94060 <1% 4,286 $406K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 43,381 $402K
90834 Psychotherapy session, about 45 minutes <1% 4,407 $392K
12001 <1% 1,443 $381K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 2,362 $380K
95816 <1% 1,528 $369K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 9,863 $365K
96415 <1% 905 $364K
73564 <1% 5,421 $334K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 32,028 $330K
73610 <1% 7,319 $328K
76870 <1% 2,205 $320K
92551 <1% 1,818 $314K
92522 <1% 1,958 $313K
97803 <1% 3,365 $294K
96375 Therapeutic injection; each additional sequential IV push <1% 9,258 $294K
92526 <1% 3,836 $293K
A0427 Emergency ambulance ride, advanced life support <1% 1,098 $290K
76536 <1% 1,737 $289K
70486 <1% 1,139 $275K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 17,208 $267K
G0390 Trauma response team associated with hospital critical care service <1% 362 $266K
76885 <1% 1,502 $262K
73630 <1% 6,741 $261K
73100 <1% 3,969 $260K
76937 <1% 2,844 $260K
77072 <1% 4,088 $258K
29125 <1% 2,275 $258K
73090 <1% 5,259 $256K
73590 <1% 5,400 $254K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 17,670 $252K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 20,655 $249K
25600 <1% 387 $234K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV <1% 10,383 $230K
76882 <1% 1,634 $229K
74240 <1% 1,225 $227K
73140 <1% 5,606 $226K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 17,198 $225K
73521 <1% 3,699 $221K
87086 Culture, bacterial; quantitative colony count, urine <1% 35,082 $219K
96127 <1% 4,978 $210K
72081 <1% 3,639 $208K
J8499 Prescription drug, oral, non chemotherapeutic, nos <1% 214,129 $206K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 7,495 $205K
43762 <1% 944 $204K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 386 $204K
97802 <1% 3,739 $203K
87507 <1% 2,291 $202K
99174 <1% 1,891 $192K
93320 <1% 3,035 $187K
29515 <1% 1,589 $186K
83655 <1% 12,357 $185K
84439 <1% 18,427 $184K
40819 <1% 110 $176K
73070 <1% 2,567 $171K
80048 Basic metabolic panel (calcium, ionized) <1% 14,839 $171K
10060 <1% 532 $168K
36415 Collection of venous blood by venipuncture <1% 52,793 $164K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 22,107 $164K
80050 General health panel <1% 11,818 $163K
96450 <1% 309 $162K
73130 <1% 3,604 $156K
93225 <1% 1,359 $155K
86922 <1% 3,247 $153K
95700 <1% 853 $152K
G0108 Diabetes outpatient self-management training services, individual, per 30 minutes <1% 1,999 $152K
49591 <1% 29 $152K
96409 <1% 1,220 $147K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 4,323 $146K
73110 <1% 3,243 $144K
96367 <1% 1,350 $144K
29105 <1% 1,225 $142K
97535 Self-care/home management training, each 15 minutes <1% 3,278 $142K
86140 <1% 21,191 $141K
80061 Lipid panel <1% 18,090 $140K
99173 <1% 4,749 $140K
72100 <1% 1,944 $140K
74230 <1% 1,026 $140K
87506 <1% 1,379 $139K
73560 <1% 2,311 $138K
73080 <1% 2,976 $132K
S0119 Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) <1% 27,457 $132K
83036 Hemoglobin; glycosylated (A1C) <1% 19,164 $132K
95951 <1% 212 $131K
51600 <1% 509 $127K
73552 <1% 2,311 $127K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 34,642 $127K
81025 <1% 18,005 $126K
J2704 Injection, propofol, 10 mg <1% 29,579 $124K
53020 <1% 103 $122K
99224 <1% 92 $120K
90837 Psychotherapy session, about an hour <1% 1,117 $120K
87040 <1% 5,758 $120K
73030 <1% 2,108 $118K
94664 <1% 13,877 $116K
99204 Doctor's office visit, new patient (more involved) <1% 799 $114K
73620 <1% 1,933 $109K
86902 <1% 1,872 $107K
73600 <1% 1,690 $106K
93226 <1% 906 $105K
97167 <1% 1,027 $101K
74455 <1% 469 $100K
73562 <1% 2,265 $99K
84443 Thyroid stimulating hormone (TSH) <1% 11,031 $98K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 36,414 $95K
99381 <1% 849 $94K
81001 <1% 25,458 $92K
96130 <1% 125 $90K
99051 <1% 38,300 $89K
82728 <1% 11,119 $89K
87077 <1% 14,180 $85K
70250 <1% 1,431 $85K
76506 <1% 529 $85K
36592 <1% 3,991 $81K
96160 <1% 2,390 $80K
90472 Immunization administration, each additional vaccine (list separately) <1% 12,243 $79K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 1,294 $79K
90686 <1% 8,930 $79K
83020 <1% 4,850 $78K
J2357 Injection, omalizumab, 5 mg <1% 1,163 $75K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 390 $74K
82784 <1% 9,812 $72K
70491 <1% 172 $72K
83516 <1% 7,574 $71K
73000 <1% 1,335 $70K
96376 <1% 2,133 $69K
77077 <1% 1,041 $67K
J0561 Injection, penicillin g benzathine, 100,000 units <1% 643 $66K
90832 Psychotherapy session, about 30 minutes <1% 935 $66K
J0585 Injection, onabotulinumtoxina, 1 unit <1% 113 $66K
97163 <1% 1,184 $66K
73660 <1% 1,674 $65K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 18,406 $64K
82247 <1% 9,229 $64K
87070 <1% 7,426 $62K
83690 <1% 7,816 $62K
90651 <1% 2,591 $62K
80306 <1% 5,404 $61K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 4,072 $61K
93788 <1% 581 $60K
71045 Radiologic examination, chest; single view <1% 2,179 $58K
A9575 Injection, gadoterate meglumine, 0.1 ml <1% 4,062 $58K
P9040 Red blood cells, leukocytes reduced, irradiated, each unit <1% 115 $56K
81003 <1% 26,504 $56K
72040 <1% 1,133 $55K
87186 <1% 8,969 $55K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 15,401 $54K
82570 <1% 10,408 $53K
J2270 Injection, morphine sulfate, up to 10 mg <1% 12,983 $53K
72125 Computed tomography, cervical spine; without contrast material <1% 256 $52K
85652 <1% 17,922 $52K
97010 <1% 2,931 $51K
72141 <1% 132 $51K
C1889 Implantable/insertable device, not otherwise classified <1% 489 $51K
J0690 Injection, cefazolin sodium, 500 mg <1% 8,978 $51K
90670 <1% 4,471 $51K
J7611 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg <1% 11,890 $50K
97116 <1% 1,425 $50K
92610 <1% 170 $50K
J1050 Injection, medroxyprogesterone acetate, 1 mg <1% 1,696 $50K
99195 <1% 815 $49K
93886 <1% 221 $49K
82248 <1% 14,109 $48K
90633 <1% 3,250 $48K
92611 <1% 859 $47K
80047 <1% 2,650 $47K
85045 <1% 14,045 $46K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 1,802 $46K
49452 <1% 118 $46K
97016 <1% 1,411 $45K
97014 <1% 1,414 $45K
76642 <1% 285 $44K
80076 <1% 4,085 $44K
J1815 Injection, insulin, per 5 units <1% 491 $44K
97760 <1% 523 $43K
72070 <1% 685 $42K
82803 <1% 3,442 $42K
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 3,387 $41K
86003 <1% 2,870 $40K
82948 <1% 4,428 $40K
A0425 Ground mileage, per statute mile <1% 1,779 $40K
97542 <1% 480 $39K
64643 <1% 43 $39K
93786 <1% 382 $39K
73060 <1% 912 $38K
82977 <1% 9,672 $37K
72170 <1% 1,015 $37K
90698 <1% 4,525 $36K
99201 <1% 336 $36K
S9083 Global fee urgent care centers <1% 465 $36K
J1439 Injection, ferric carboxymaltose, 1 mg <1% 64 $36K
J8540 Dexamethasone, oral, 0.25 mg <1% 10,065 $35K
73502 <1% 522 $35K
90680 <1% 4,130 $35K
J7644 Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram <1% 9,301 $34K
54640 <1% 37 $34K
87510 <1% 2,583 $34K
83735 <1% 10,538 $34K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 4,710 $34K
88312 <1% 4,731 $33K
Q5104 Injection, infliximab-abda, biosimilar, (renflexis), 10 mg <1% 13 $32K
83001 <1% 2,046 $32K
J8597 Antiemetic drug, oral, not otherwise specified <1% 884 $31K
82330 <1% 3,986 $31K
88300 <1% 3,250 $30K
77073 <1% 411 $29K
69209 <1% 405 $29K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 5,176 $29K
85027 <1% 6,392 $29K
88304 <1% 2,073 $28K
90792 Psychiatric diagnostic evaluation with medical services <1% 58 $28K
J0171 Injection, adrenalin, epinephrine, 0.1 mg <1% 2,320 $27K
C1769 Guide wire <1% 913 $27K
97763 <1% 529 $26K
84146 <1% 1,840 $25K
86901 <1% 4,967 $24K
69210 <1% 163 $24K
87660 <1% 2,581 $24K
29075 <1% 92 $23K
86592 <1% 4,061 $23K
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg <1% 9,880 $23K
83880 <1% 1,021 $22K
J1644 Injection, heparin sodium, per 1000 units <1% 7,290 $22K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 7,729 $22K
84100 <1% 13,961 $22K
86850 <1% 4,463 $21K
83550 <1% 5,542 $21K
85007 <1% 5,276 $21K
86038 <1% 2,785 $21K
86900 <1% 4,968 $21K
92609 <1% 499 $20K
96112 <1% 20 $20K
29405 <1% 92 $20K
82785 <1% 2,150 $20K
S0077 Injection, clindamycin phosphate, 300 mg <1% 1,684 $20K
90671 <1% 865 $20K
83540 <1% 6,167 $19K
80197 <1% 2,300 $19K
76942 <1% 233 $19K
80143 <1% 672 $19K
85018 <1% 5,745 $19K
J7342 Instillation, ciprofloxacin otic suspension, 6 mg <1% 914 $19K
82150 <1% 2,658 $18K
90677 <1% 1,290 $18K
90715 <1% 1,790 $18K
36591 <1% 630 $18K
72197 <1% 28 $18K
87480 <1% 2,565 $18K
82947 <1% 3,843 $18K
95805 <1% 27 $17K
90744 <1% 2,295 $17K
85610 <1% 5,505 $17K
90696 <1% 1,294 $17K
82043 <1% 6,140 $16K
80179 <1% 642 $16K
97755 <1% 72 $16K
A4580 Cast supplies (e.g., plaster) <1% 623 $15K
85660 <1% 2,201 $15K
90619 <1% 1,050 $15K
87205 <1% 4,214 $15K
90697 <1% 2,052 $15K
95811 <1% 12 $15K
82550 <1% 2,629 $14K
C1729 Catheter, drainage <1% 2,003 $14K
87101 <1% 1,705 $14K
90710 <1% 1,464 $14K
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme <1% 4,668 $13K
J2795 Injection, ropivacaine hydrochloride, 1 mg <1% 2,702 $13K
84156 <1% 4,724 $12K
82657 <1% 797 $12K
80299 <1% 586 $12K
85730 <1% 4,319 $12K
86308 <1% 1,856 $12K
97033 <1% 418 $12K
85014 <1% 7,766 $12K
82565 <1% 3,776 $12K
90661 <1% 1,435 $12K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 67 $11K
84145 <1% 1,014 $11K
95715 <1% 16 $11K
83605 <1% 1,261 $11K
86160 <1% 1,420 $11K
90716 <1% 1,382 $11K
99395 Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years <1% 92 $11K
95708 <1% 15 $11K
97113 <1% 199 $11K
90707 <1% 1,357 $11K
77080 <1% 83 $11K
92652 <1% 76 $10K
83615 <1% 4,904 $10K
84295 <1% 2,740 $10K
90620 <1% 937 $10K
12002 <1% 37 $10K
90380 <1% 53 $10K
97750 <1% 234 $10K
96139 <1% 87 $9K
90480 <1% 237 $9K
J0290 Injection, ampicillin sodium, 500 mg <1% 1,339 $8K
71250 <1% 26 $8K
84132 <1% 3,868 $8K
90853 Group psychotherapy (other than of a multiple-family group) <1% 65 $8K
84450 <1% 3,019 $8K
72110 <1% 97 $8K
84550 <1% 5,296 $8K
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 2,514 $8K
51701 <1% 1,235 $8K
86480 <1% 739 $8K
84460 <1% 3,133 $8K
87075 <1% 314 $7K
90734 <1% 714 $7K
73120 <1% 126 $7K
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units <1% 3,376 $7K
76800 <1% 42 $7K
92607 <1% 27 $7K
84484 <1% 488 $7K
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 1,747 $7K
Q9963 High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml <1% 445 $7K
77076 <1% 109 $7K
J0330 Injection, succinylcholine chloride, up to 20 mg <1% 784 $6K
86430 <1% 1,409 $6K
99205 Prolong outpt/office vis <1% 46 $6K
16020 <1% 27 $6K
88302 <1% 991 $6K
S0020 Injection, bupivicaine hydrochloride, 30 ml <1% 1,021 $6K
J1756 Injection, iron sucrose, 1 mg <1% 350 $6K
89051 <1% 1,438 $6K
64642 <1% 56 $6K
36416 <1% 4,613 $5K
J0134 Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg <1% 1,030 $5K
97166 <1% 41 $5K
96132 <1% 60 $5K
93975 <1% 12 $5K
82465 <1% 2,560 $5K
74270 <1% 25 $5K
82272 <1% 1,329 $5K
24640 <1% 12 $5K
87807 <1% 456 $5K
83993 <1% 538 $5K
86008 <1% 464 $5K
17250 <1% 12 $4K
90672 <1% 328 $4K
J9370 Vincristine sulfate, 1 mg <1% 893 $4K
Q9958 High osmolar contrast material, up to 149 mg/ml iodine concentration, per ml <1% 461 $4K
86665 <1% 371 $4K
87102 <1% 315 $4K
92585 <1% 27 $4K
J2182 Injection, mepolizumab, 1 mg <1% 26 $4K
J0737 Injection, clindamycin phosphate (baxter), not therapeutically equivalent to j0736, 300 mg <1% 446 $4K
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg <1% 669 $4K
L1830 Knee orthosis, immobilizer, canvas longitudinal, prefabricated, off-the-shelf <1% 130 $3K
29130 <1% 58 $3K
12051 <1% 13 $3K
J0694 Injection, cefoxitin sodium, 1 gm <1% 213 $3K
86663 <1% 341 $3K
J0780 Injection, prochlorperazine, up to 10 mg <1% 418 $3K
96137 <1% 43 $3K
L3260 Surgical boot/shoe, each <1% 166 $3K
0071A <1% 61 $3K
91322 <1% 98 $3K
74022 <1% 40 $3K
84480 <1% 450 $3K
86039 <1% 505 $2K
29540 <1% 13 $2K
Q4081 Injection, epoetin alfa, 100 units (for esrd on dialysis) <1% 104 $2K
94726 <1% 25 $2K
0072A <1% 53 $2K
94729 <1% 41 $2K
74183 <1% 14 $2K
31720 <1% 26 $2K
0002A <1% 59 $2K
96131 <1% 44 $2K
90833 Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) <1% 45 $2K
86664 <1% 361 $2K
93971 <1% 14 $2K
J1170 Injection, hydromorphone, up to 4 mg <1% 265 $2K
90474 <1% 3,617 $2K
83970 <1% 532 $2K
J2469 Injection, palonosetron hcl, 25 mcg <1% 109 $2K
94761 <1% 1,581 $2K
0001A <1% 60 $2K
82270 <1% 488 $2K
85245 <1% 169 $2K
85384 <1% 464 $2K
96411 <1% 15 $2K
87529 <1% 105 $2K
88342 <1% 154 $2K
96381 <1% 199 $2K
J7510 Prednisolone oral, per 5 mg <1% 816 $2K
J7999 Compounded drug, not otherwise classified <1% 509 $1K
87081 <1% 352 $1K
96138 <1% 47 $1K
80164 <1% 131 $1K
J7699 Noc drugs, inhalation solution administered through dme <1% 511 $1K
J2550 Injection, promethazine hcl, up to 50 mg <1% 441 $1K
A4565 Slings <1% 196 $1K
83986 <1% 450 $1K
B4088 Gastrostomy/jejunostomy tube, low-profile, any material, any type, each <1% 55 $1K
85246 <1% 201 $1K
J3489 Injection, zoledronic acid, 1 mg <1% 13 $1K
85240 <1% 98 $992.82
94760 <1% 1,470 $956.09
91321 <1% 110 $923.63
84478 <1% 302 $891.21
64448 <1% 18 $829.95
85379 <1% 57 $745.21
88313 <1% 48 $717.84
80349 <1% 106 $714.87
82010 <1% 103 $710.58
J3475 Injection, magnesium sulfate, per 500 mg <1% 189 $697.08
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 321 $686.05
90381 <1% 82 $628.02
93296 <1% 19 $561.46
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 50 $523.03
0124A <1% 17 $518.59
J0295 Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm <1% 76 $507.83
J2919 Injection, methylprednisolone sodium succinate, 5 mg <1% 252 $487.92
82533 <1% 26 $475.71
J3370 Injection, vancomycin hcl, 500 mg <1% 63 $469.01
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg <1% 162 $460.03
87252 <1% 13 $440.11
85055 <1% 75 $429.99
80069 <1% 78 $420.76
90473 <1% 178 $415.35
87496 <1% 14 $398.06
82310 <1% 579 $381.48
86769 <1% 64 $349.76
84157 <1% 360 $339.34
83718 <1% 27 $329.68
90732 <1% 13 $324.30
82040 <1% 69 $323.48
84703 <1% 37 $321.83
S0080 Injection, pentamidine isethionate, 300 mg <1% 12 $317.04
J2060 Injection, lorazepam, 2 mg <1% 56 $306.20
82670 <1% 174 $299.65
J7626 Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg <1% 150 $280.23
82945 <1% 256 $275.46
87220 <1% 74 $246.69
82607 <1% 58 $222.54
84520 <1% 245 $222.10
J2920 Injection, methylprednisolone sodium succinate, up to 40 mg <1% 75 $217.31
J2370 Injection, phenylephrine hcl, up to 1 ml <1% 28 $198.46
85670 <1% 21 $194.04
J7610 Albuterol, inhalation solution, compounded product, administered through dme, concentrated form, 1 mg <1% 17 $173.75
99199 Unlisted special service, procedure or report <1% 22 $169.40
86803 <1% 199 $161.98
J0610 Injection, calcium gluconate (fresenius kabi), per 10 ml <1% 33 $152.12
95004 Percutaneous tests with allergenic extracts, immediate type reaction <1% 14 $149.88
86706 <1% 224 $146.66
86880 <1% 41 $146.15
87118 <1% 14 $143.15
90785 <1% 14 $140.92
29505 <1% 13 $136.22
87206 <1% 14 $131.90
83002 <1% 352 $130.13
82438 <1% 13 $118.82
S0164 Injection, pantoprazole sodium, 40 mg <1% 16 $115.68
89055 <1% 31 $109.97
83519 <1% 240 $107.41
84134 <1% 12 $99.09
82340 <1% 39 $98.12
86225 <1% 104 $73.70
82140 <1% 15 $73.58
85651 <1% 15 $71.52
84402 <1% 217 $71.33
Q9965 Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml <1% 13 $54.01
87184 <1% 16 $46.13
87340 <1% 292 $40.65
87147 <1% 14 $34.24
82435 <1% 69 $32.88
J1626 Injection, granisetron hydrochloride, 100 mcg <1% 92 $29.37
86255 <1% 24 $28.00
87497 <1% 14 $24.01
82610 <1% 145 $8.31
J9250 Methotrexate sodium, 5 mg <1% 14 $6.66
Q0144 Azithromycin dihydrate, oral, capsules/powder, 1 gram <1% 402 $5.45
A4606 Oxygen probe for use with oximeter device, replacement <1% 617 $5.33
91312 <1% 17 $5.09
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 28 $2.46
A4550 Surgical trays 0% 40 $0.00
G9920 Screening performed and negative 0% 3,719 $0.00
82627 0% 26 $0.00
84030 0% 49 $0.00
86235 0% 14 $0.00
G8431 Screening for depression is documented as being positive and a follow-up plan is documented 0% 436 $0.00
A4218 Sterile saline or water, metered dose dispenser, 10 ml 0% 18 $0.00
96136 0% 14 $0.00
J2004 Injection, lidocaine hcl with epinephrine, 1 mg 0% 118 $0.00
J1171 Injection, hydromorphone, 0.1 mg 0% 40 $0.00
87799 0% 39 $0.00
G9919 Screening performed and positive and provision of recommendations 0% 809 $0.00
90685 0% 29 $0.00
J1596 Injection, glycopyrrolate, 0.1 mg 0% 518 $0.00
86352 0% 41 $0.00
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen 0% 364 $0.00
A4627 Spacer, bag or reservoir, with or without mask, for use with metered dose inhaler 0% 473 $0.00
G8510 Screening for depression is documented as negative, a follow-up plan is not required 0% 2,866 $0.00
83498 0% 13 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialABSHIRE, KATHRYN (SENIOR VP/CFO)
Same official

Other billing entities under ABSHIRE, KATHRYN

Full network →
ProviderLocationPaid
Childrens Hospital of the Kings Daughters INCNorfolk, VA$10.18M
Childrens Medical Group INCNorfolk, VA$9.18M
Childrens Hospital of the Kings Daughters INCNorfolk, VA$8.38M
Childrens Medical Group INCNewport News, VA$7.11M
Childrens Medical Group INCVirginia Beach, VA$5.72M
Childrens Medical Group INCNorfolk, VA$4.85M
Childrens Medical Group INCHampton, VA$4.67M
Children's Surgical Specialty Group, INCNorfolk, VA$3.98M
Childrens Medical Group INCNorfolk, VA$3.58M
Childrens Medical Group INCSuffolk, VA$3.46M
Childrens Medical Group INCVirginia Beach, VA$3.22M
Childrens Medical Group INCChesapeake, VA$3.06M
Children's Medical Group, INC., D/B/A Liberty PediatricsNewport News, VA$2.98M
Childrens Medical Group INCSuffolk, VA$2.36M
Childrens Medical Group INCVirginia Beach, VA$2.30M
Childrens Medical Group INCWilliamsburg, VA$2.23M
Childrens Medical Group INCNorfolk, VA$2.10M
Children's Medical Group, INC., D/B/A Courthouse PediatricsGloucester, VA$2.10M
Childrens Medical Group INCChesapeake, VA$805K
Childrens Medical Group INCVirginia Beach, VA$617K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.